Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005298
Filing Date
2016-05-04
Accepted
2016-05-04 16:31:48
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20160331x10q.htm 10-Q 1548555
2 EX-31.1 immu-20160331ex31187bab6.htm EX-31.1 16166
3 EX-31.2 immu-20160331ex31256d014.htm EX-31.2 16908
4 EX-32.1 immu-20160331ex321fec2b5.htm EX-32.1 12848
  Complete submission text file 0001558370-16-005298.txt   6111785

Data Files

Seq Description Document Type Size
5 EX-101.INS immu-20160331.xml EX-101.INS 1467043
6 EX-101.SCH immu-20160331.xsd EX-101.SCH 34872
7 EX-101.CAL immu-20160331_cal.xml EX-101.CAL 43892
8 EX-101.DEF immu-20160331_def.xml EX-101.DEF 110779
9 EX-101.LAB immu-20160331_lab.xml EX-101.LAB 315988
10 EX-101.PRE immu-20160331_pre.xml EX-101.PRE 257185
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 161619870
SIC: 2835 In Vitro & In Vivo Diagnostic Substances